Virax Biolabs Group annual gross margin
2021
2023
2024
2025
2026
Virax Biolabs Group Gross Margin Growth & History (VRAX)
Virax Biolabs Group's gross margin was 61.90% for fiscal 2026.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | 61.90% | +900.11 pp |
| 2025 | 2025-03-31 | −838.21% | −870.55 pp |
| 2024 | 2024-03-31 | 32.34% | +48.29 pp |
| 2023 | 2023-03-31 | −15.94% | — |
| 2021 | 2021-03-31 | −7.62% | — |
Virax Biolabs Group gross margin trends
Over the last five fiscal years, Virax Biolabs Group's gross margin increased from −7.62% to 61.90%, a change of +69.52 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Virax Biolabs Group source filings ↗